✨ Education and Health Notices
8 DECEMBER 2011 NEW ZEALAND GAZETTE, No. 189 5463
Dated at Wellington this 29th day of November 2011.
JEREMY WOOD, Group Manager, Education, Curriculum and Performance, Ministry of Education.
go8407
St Matthew’s Primary School (Attendance Dues) Notice 2011
Under section 36(2) of the Private Schools Conditional Integration Act 1975, and acting with authority delegated by the Minister of Education, I approve that the attendance dues payable in respect of any pupil at St Matthew’s Primary School shall be a maximum of $720.00 (exclusive of GST) per annum.
Dated at Wellington this 1st day of December 2011.
JEREMY WOOD, Group Manager, Education, Curriculum and Performance, Ministry of Education.
go8527
Health
Medicines Act 1981
Provisional Consent to the Distribution of New Medicines
Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Rapamune
Active Ingredient: Sirolimus 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Wyeth Pharmaceuticals Inc, New York, United States of America
Patheon Inc, Ontario, Canada
Note: This consent is valid for two years from the date of publication of this notice.
Product: Rapamune
Active Ingredient: Sirolimus 1mg
Dosage Form: Tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Wyeth Pharmaceutical Company, Guayama, Puerto Rico
Wyeth Pharmaceuticals Inc, New York, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 5th day of December 2011.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8507
Renewal of Provisional Consent to the Distribution of a Medicine
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Rapamune
Active Ingredient: Sirolimus 2mg
Dosage Form: Coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Wyeth Pharmaceutical Company, Guayama, Puerto Rico
Wyeth Pharmaceuticals Inc, New York, United States of America
Note: This renewed consent is valid for two years from 12 January 2012.
Dated this 5th day of December 2011.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8508
Next Page →
✨ LLM interpretation of page content
🎓 St Matthew’s Primary School (Attendance Dues) Notice 2011
🎓 Education, Culture & Science1 December 2011
Attendance Dues, Private School, St Matthew’s Primary School
- JEREMY WOOD, Group Manager, Education, Curriculum and Performance, Ministry of Education
🏥 Provisional Consent to the Distribution of New Medicines
🏥 Health & Social Welfare5 December 2011
Medicines, Provisional Consent, Rapamune, Sirolimus
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🏥 Renewal of Provisional Consent to the Distribution of a Medicine
🏥 Health & Social Welfare5 December 2011
Medicines, Renewal of Provisional Consent, Rapamune, Sirolimus
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
NZ Gazette 2011, No 189